WESPAC Advisors LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

WESPAC Advisors LLC acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 1,509 shares of the biotechnology company’s stock, valued at approximately $897,000.

Other large investors also recently modified their holdings of the company. Public Sector Pension Investment Board grew its stake in shares of Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the period. CIBC Asset Management Inc boosted its holdings in shares of Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after acquiring an additional 895 shares in the last quarter. Foundations Investment Advisors LLC acquired a new position in shares of Axon Enterprise in the 3rd quarter worth approximately $221,000. Sequoia Financial Advisors LLC boosted its holdings in shares of Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after acquiring an additional 81 shares in the last quarter. Finally, Axxcess Wealth Management LLC acquired a new position in shares of Axon Enterprise in the 3rd quarter worth approximately $814,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $513.22 on Friday. The firm has a fifty day moving average of $619.94 and a two-hundred day moving average of $518.66. The stock has a market capitalization of $39.13 billion, a price-to-earnings ratio of 132.62, a PEG ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a 52 week low of $265.32 and a 52 week high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the sale, the insider now owns 128,542 shares in the company, valued at approximately $84,168,016.18. The trade was a 1.76 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now owns 2,392 shares of the company’s stock, valued at $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,711 shares of company stock worth $5,631,561. Insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on AXON. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. The Goldman Sachs Group boosted their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Finally, TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $561.31.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.